Zydus Wellness Limited (BOM:531335)
India · Delayed Price · Currency is INR 476.50
-12.15 (-2.49%)
At close: Nov 5, 2026
Zydus Wellness Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 50,190 | 39,610 | 27,089 | 23,278 | 22,548 | 20,091 |
Revenue Growth | 73.88% | 46.22% | 16.37% | 3.24% | 12.23% | 7.63% |
Gross Profit Gross Profit Growth | 31,924 | 23,709 | 14,133 | 11,739 | 10,955 | 10,165 |
Operating Income Operating Income Growth | 4,338 | 3,557 | 3,518 | 2,843 | 3,125 | 3,220 |
Net Income Net Income Growth | 2,461 | 1,972 | 3,469 | 2,669 | 3,104 | 3,089 |
Earnings Per Share EPS Growth | 7.74 | 6.20 | 10.90 | 8.39 | 9.76 | 9.71 |
EPS Growth | -2.82% | -43.15% | 29.97% | -14.01% | 0.50% | 148.33% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,620 | 1,149 | 1,092 | 3,160 | 1,076 | 1,963 |
Total Debt Total Debt Growth | 31,673 | 32,028 | 1,883 | 3,287 | 2,973 | 3,873 |
Net Cash (Debt) Net Cash Growth | -29,053 | -30,879 | -791 | -127 | -1,897 | -1,911 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -91.35 | -97.05 | -2.49 | -0.40 | -5.96 | -6.01 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 4,454 | 2,264 | 3,800 | 2,464 | 917 | 2,369 |
Capital Expenditures CapEx Growth | -771 | -1,017 | -663 | -285 | -450 | -754.4 |
Free Cash Flow Free Cash Flow Growth | 3,683 | 1,247 | 3,137 | 2,179 | 467 | 1,614 |
Free Cash Flow Growth | 502.78% | -60.25% | 43.96% | 366.60% | -71.07% | -39.56% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 63.61% | 59.86% | 52.17% | 50.43% | 48.59% | 50.59% |
Operating Margin | 8.64% | 8.98% | 12.99% | 12.21% | 13.86% | 16.03% |
Pretax Margin | 6.09% | 5.82% | 13.25% | 11.17% | 12.90% | 15.23% |
Profit Margin | 4.90% | 4.98% | 12.81% | 11.47% | 13.77% | 15.37% |
FCF Margin | 7.34% | 3.15% | 11.58% | 9.36% | 2.07% | 8.03% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.200 | 1.200 | 1.200 | 1.000 | 1.000 | 1.000 |
Dividend Per Share Growth | 0% | 0% | 20.00% | 0% | 0% | 0% |
Dividend Yield | 0.25% | 0.28% | 0.36% | 0.34% | 0.32% | 0.33% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 61.58 | 68.75 | 30.66 | 35.07 | 31.77 | 30.92 |
Forward PE | 33.65 | 38.20 | 24.90 | 24.86 | 24.44 | 24.87 |
P/FCF Ratio | 41.16 | 108.72 | 33.91 | 42.95 | 211.19 | 59.16 |
PS Ratio | 3.02 | 3.42 | 3.93 | 4.02 | 4.37 | 4.75 |